ALMS was a well-designed, randomized, controlled trial that included 370 patients with systemic lupus erythematosus (SLE) and class III, IV, or V nephritis. Like every recent major trial of new ...

Conventional lupus nephritis (LN) treatment based on cyclophosphamide, steroids and, recently, mycophenolatemofetil has improved the outcome of the disease over the last 50 years, although failure ...

The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.

biopsy-proven lupus nephritis (class III-V) and evidence of active disease (e.g. elevated serum creatinine concentration, proteinuria or microscopic hematuria), were prospectively recruited in ...

Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...

Lower glucocorticoid dosages were significantly more common with belimumab. Children with lupus nephritis who receive belimumab achieve treatment targets faster, and can taper glucocorticoids ...

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541 ... aimed at treating Lupus Nephritis. This development marks a significant step for the company as it continues to advance its ...

Our Bureau, Bengaluru Friday, January 24, 2025, 14:30 Hrs [IST] ...

This partnership combines LIVEKIDNEY.BIO's pioneering work in lupus treatment with Isotopia's world-class manufacturing ... Understanding Lupus Nephritis Lupus is a chronic autoimmune disease ...

In June 2020, I started showing symptoms of joint pain, bloodshot eyes, fatigue, fevers, and chills. After 3 major hospital stays, I was diagnosed in September of 2020 with Lupus Nephritis Class IV ...

The partnership focuses on the first-in-class therapeutic, in conjunction with Henlius' HANLIKANG (rituximab), for individuals with autoimmune conditions such as lupus nephritis. Henlius has ...